Skip to main content

JPMORGAN CHASE & CO

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,353,364,036
-$978,109,742 QoQ
Shares Held
3,774,199
-12.5% QoQ
Ownership
3.67%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#6
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 90% Shared 1% None 9%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. REGN ranks #2 (18.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
3,774,199 $2,353,364,036

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,353,364,036 3,774,199
2026-03-31 $3,331,473,778 4,311,806
2025-12-31 $3,041,291,289 3,940,160
2025-09-30 $2,289,746,729 4,072,326
2025-06-30 $2,068,299,450 3,939,618
2025-03-31 $3,588,598,271 5,658,197
2024-12-31 $5,028,601,731 7,059,371
2024-09-30 $7,873,261,968 7,489,500
2024-06-30 $8,699,706,374 8,277,315
2024-03-31 $7,437,327,694 7,727,174
2023-12-31 $6,347,198,936 7,226,769
2023-09-30 $6,080,978,165 7,389,154
2023-06-30 $4,702,116,410 6,543,987
2023-03-31 $5,212,798,542 6,344,151
2022-12-31 $4,407,975,611 6,109,545
2022-09-30 $3,930,601,969 5,705,869
2022-06-30 $3,356,691,500 5,678,432
2022-03-31 $3,467,632,244 4,964,967
2021-12-31 $2,899,642,386 4,591,529
2021-09-30 $2,482,717,657 4,102,445
2021-06-30 $2,115,969,021 3,788,393
2021-03-31 $1,436,289,799 3,035,655
2020-12-31 $1,118,106,876 2,314,394
2020-09-30 $1,076,655,096 1,923,354
2020-06-30 $1,120,992,158 1,797,470
2020-03-31 $600,310,068 1,229,413